The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes-Reference-Cited by-同舟云学术

The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes

Published:2023-03 Issue: Volume:Volume 17 Page:793-805
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Gelhorn Heather L,Osumili Beatrice^ORCID,Brown Katelyn,Ross Melissa M^ORCID,Schulz Andrea,Fernandez Gabriela,Boye Kristina S

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference33 articles.

1. World Health Organization. Diabetes; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed March 13, 2023.

2. Centers for Disease Control and Prevention. National diabetes statistics report; 2022. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed March 13, 2023.

3. Diabetes UK. Diabetes statistics; 2022. Available from: https://www.diabetes.org.uk/professionals/position-statements-reports/statistics. Accessed March 13, 2023.

4. Centers for Disease Control and Prevention. Type 2 diabetes; 2022. Available from: https://www.cdc.gov/diabetes/basics/type2.html. Accessed March 13, 2023.

5. American Diabetes Association. Understanding A1C: diagnosis; 2022. Available from: https://www.diabetes.org/diabetes/a1c. Accessed March 13, 2023.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States;Diabetes Therapy;2023-11-18